Genetic Characterization of 191 Probands with Inherited Retinal Dystrophy by Targeted NGS Analysis.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
12 Jun 2024
Historique:
received: 10 05 2024
revised: 04 06 2024
accepted: 08 06 2024
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 27 6 2024
Statut: epublish

Résumé

Inherited retinal diseases (IRDs) represent a frequent cause of blindness in children and adults. As a consequence of the phenotype and genotype heterogeneity of the disease, it is difficult to have a specific diagnosis without molecular testing. To date, over 340 genes and loci have been associated with IRDs. We present the molecular finding of 191 individuals with IRD, analyzed by targeted next-generation sequencing (NGS). For 67 of them, we performed a family segregation study, considering a total of 126 relatives. A total of 359 variants were identified, 44 of which were novel. Genetic diagnostic yield was 41%. However, after stratifying the patients according to their clinical suspicion, diagnostic yield was higher for well-characterized diseases such as Stargardt disease (STGD), at 65%, and for congenital stationary night blindness 2 (CSNB2), at 64%. Diagnostic yield was higher in the patient group where family segregation analysis was possible (68%) and it was higher in younger (55%) than in older patients (33%). The results of this analysis demonstrated that targeted NGS is an effective method for establishing a molecular genetic diagnosis of IRDs. Furthermore, this study underlines the importance of segregation studies to understand the role of genetic variants with unknow pathogenic role.

Identifiants

pubmed: 38927702
pii: genes15060766
doi: 10.3390/genes15060766
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Italian Minister of Health
ID : 12C401

Auteurs

Alessandra Mihalich (A)

Molecular Biology Laboratory, Istituto Auxologico Italiano IRCCS, 20145 Milan, Italy.
Neuro-Ophthalmology Center and Electrophysiology Laboratory, Department of Ophthalmology, Istituto Auxologico Italiano IRCCS, 20145 Milan, Italy.

Gabriella Cammarata (G)

Neuro-Ophthalmology Center and Electrophysiology Laboratory, Department of Ophthalmology, Istituto Auxologico Italiano IRCCS, 20145 Milan, Italy.

Gemma Tremolada (G)

Neuro-Ophthalmology Center and Electrophysiology Laboratory, Department of Ophthalmology, Istituto Auxologico Italiano IRCCS, 20145 Milan, Italy.

Emanuela Manfredini (E)

Molecular Biology Laboratory, Istituto Auxologico Italiano IRCCS, 20145 Milan, Italy.

Stefania Bianchi Marzoli (S)

Neuro-Ophthalmology Center and Electrophysiology Laboratory, Department of Ophthalmology, Istituto Auxologico Italiano IRCCS, 20145 Milan, Italy.

Anna Maria Di Blasio (AM)

Molecular Biology Laboratory, Istituto Auxologico Italiano IRCCS, 20145 Milan, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH